IL139371A0 - Feline dc80, feline cd86, feline dc28 and feline ctla-4 nucleic acid and polyptides - Google Patents

Feline dc80, feline cd86, feline dc28 and feline ctla-4 nucleic acid and polyptides

Info

Publication number
IL139371A0
IL139371A0 IL13937199A IL13937199A IL139371A0 IL 139371 A0 IL139371 A0 IL 139371A0 IL 13937199 A IL13937199 A IL 13937199A IL 13937199 A IL13937199 A IL 13937199A IL 139371 A0 IL139371 A0 IL 139371A0
Authority
IL
Israel
Prior art keywords
feline
ctla
provides
nucleic acid
present
Prior art date
Application number
IL13937199A
Other languages
English (en)
Original Assignee
Texas A & M System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Texas A & M System filed Critical Texas A & M System
Publication of IL139371A0 publication Critical patent/IL139371A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70521—CD28, CD152
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70532—B7 molecules, e.g. CD80, CD86
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Transplantation (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL13937199A 1998-05-01 1999-04-30 Feline dc80, feline cd86, feline dc28 and feline ctla-4 nucleic acid and polyptides IL139371A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7169998A 1998-05-01 1998-05-01
PCT/US1999/009502 WO1999057271A2 (fr) 1998-05-01 1999-04-30 Acide nucleique et polypeptides des cd80, cd86, cd28 et ctla-4 felins

Publications (1)

Publication Number Publication Date
IL139371A0 true IL139371A0 (en) 2001-11-25

Family

ID=22102998

Family Applications (4)

Application Number Title Priority Date Filing Date
IL13937199A IL139371A0 (en) 1998-05-01 1999-04-30 Feline dc80, feline cd86, feline dc28 and feline ctla-4 nucleic acid and polyptides
IL139371A IL139371A (en) 1998-05-01 2000-10-30 Nucleic acids and polypeptides of CD86 ligand
IL184201A IL184201A (en) 1998-05-01 2007-06-25 Oligonucleotide with a complementary sequence to sequences found in nucleic acid encoding, of cat origin, CD4, CD28, CD86, CD86, CD80
IL184202A IL184202A (en) 1998-05-01 2007-06-25 Nuclear nuclei encoding the CTLA-4 receptor of cat origin, vectors, surrogate cells and vaccines containing them, and CTLA-4 polypeptide of cat origin

Family Applications After (3)

Application Number Title Priority Date Filing Date
IL139371A IL139371A (en) 1998-05-01 2000-10-30 Nucleic acids and polypeptides of CD86 ligand
IL184201A IL184201A (en) 1998-05-01 2007-06-25 Oligonucleotide with a complementary sequence to sequences found in nucleic acid encoding, of cat origin, CD4, CD28, CD86, CD86, CD80
IL184202A IL184202A (en) 1998-05-01 2007-06-25 Nuclear nuclei encoding the CTLA-4 receptor of cat origin, vectors, surrogate cells and vaccines containing them, and CTLA-4 polypeptide of cat origin

Country Status (20)

Country Link
EP (1) EP1073741B1 (fr)
JP (3) JP2002513571A (fr)
KR (2) KR20040053251A (fr)
AT (1) ATE481485T1 (fr)
AU (1) AU4070399A (fr)
BR (1) BR9910153A (fr)
CA (1) CA2327539A1 (fr)
CZ (1) CZ20003935A3 (fr)
DE (1) DE69942765D1 (fr)
ES (1) ES2352745T3 (fr)
HU (1) HUP0102806A3 (fr)
IL (4) IL139371A0 (fr)
NO (1) NO20005481L (fr)
NZ (1) NZ507794A (fr)
PL (1) PL199352B1 (fr)
RU (2) RU2263145C2 (fr)
SK (1) SK16172000A3 (fr)
UA (2) UA87470C2 (fr)
WO (1) WO1999057271A2 (fr)
ZA (1) ZA200006123B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7094874B2 (en) 2000-05-26 2006-08-22 Bristol-Myers Squibb Co. Soluble CTLA4 mutant molecules
US7183376B2 (en) 2000-06-23 2007-02-27 Maxygen, Inc. Variant B7 co-stimulatory molecules
EP1360290A2 (fr) 2000-06-23 2003-11-12 Maxygen, Inc. Molecules costimulatrices
RU2317329C2 (ru) * 2005-05-04 2008-02-20 Дмитрий Валериевич Федосов Пара синтетических олигонуклеотидов-праймеров, используемых для выявления днк провируса лейкоза кошек эндогенного и экзогенного типа, и условия полимеразной цепной реакции с их использованием
ES2642184T3 (es) * 2012-01-05 2017-11-15 Deutsches Krebsforschungszentrum Péptidos para su uso en el tratamiento y diagnóstico de cánceres positivos a IDH1 R132H
CN110184283A (zh) * 2019-04-30 2019-08-30 吉林农业大学 一种检测虎细小病毒的lamp-lfd试剂盒

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2658669B1 (fr) * 1990-02-20 1992-07-24 Souriau & Cie Connecteur a verrouillage par levier.
CA2580812A1 (fr) * 1991-06-27 1993-01-07 Bristol-Myers Squibb Company Recepteur ctla, proteines hybrides qui le contiennent et ses applications
WO1995006738A1 (fr) * 1993-09-03 1995-03-09 Schering Corporation B70(b7-2):proteine de liaison de ctla-4
DE69519521T2 (de) * 1994-10-03 2001-06-28 The Government Of The United States Of America, As Represented By The Secretary National Institute Of Health Zusammensetzung enthaltend ein antigen exprimierendes rekombinantes virus und ein immunstimulierendes molekül exprimierendes rekombinantes virus
JP4025400B2 (ja) * 1997-04-16 2007-12-19 財団法人化学及血清療法研究所 新規免疫制御分子及びその製造方法

Also Published As

Publication number Publication date
EP1073741B1 (fr) 2010-09-15
IL139371A (en) 2009-08-03
KR100869861B1 (ko) 2008-11-24
JP2010252804A (ja) 2010-11-11
HK1034537A1 (en) 2001-10-26
WO1999057271A9 (fr) 2000-04-27
PL199352B1 (pl) 2008-09-30
UA77382C2 (en) 2006-12-15
RU2263145C2 (ru) 2005-10-27
RU2005108676A (ru) 2006-09-10
CA2327539A1 (fr) 1999-11-11
BR9910153A (pt) 2001-10-02
EP1073741A2 (fr) 2001-02-07
DE69942765D1 (de) 2010-10-28
WO1999057271A2 (fr) 1999-11-11
IL184202A (en) 2010-11-30
WO1999057271A3 (fr) 2000-03-02
CZ20003935A3 (cs) 2001-12-12
HUP0102806A3 (en) 2005-12-28
IL184201A (en) 2010-11-30
AU4070399A (en) 1999-11-23
HUP0102806A2 (hu) 2001-11-28
JP2010104369A (ja) 2010-05-13
ES2352745T3 (es) 2011-02-22
PL345975A1 (en) 2002-01-14
KR20010082542A (ko) 2001-08-30
ATE481485T1 (de) 2010-10-15
NO20005481L (no) 2000-12-29
ZA200006123B (en) 2002-01-20
NZ507794A (en) 2003-10-31
RU2377302C2 (ru) 2009-12-27
NO20005481D0 (no) 2000-10-31
KR20040053251A (ko) 2004-06-23
UA87470C2 (ru) 2009-07-27
SK16172000A3 (sk) 2002-10-08
JP2002513571A (ja) 2002-05-14

Similar Documents

Publication Publication Date Title
AU4078599A (en) Expression vectors for stimulating an immune response and methods of using the same
BR0010361A (pt) Seq ências genÈmicas de neisseria e uso destas
AU2003278729A8 (en) Regulated bacterial lysis for gene vaccine vector delivery and antigen release
SG152917A1 (en) Neisseria meningitidis antigens
WO1999024578A3 (fr) Antigenes de neisseria
NZ532665A (en) Neisseria meningitidis antigens and compositions
WO2005025614A3 (fr) Ameliorations concernant la vaccination
MXPA01003557A (es) Secuencias genomicas de neisseria y metodos para su uso.
AU2785089A (en) Chimeric glycoproteins containing immunogenic segments of the glycoproteins of human respiratory syncytial virus
AU8127494A (en) Chimeric proteins comprising borrelia polypeptides: uses therefor
PL345975A1 (en) Feline cd80, feline cd86, feline cd28, and feline ctla-4 nucleic acid and polypeptides
EP0989858A4 (fr) Peptidomimetiques inhibiteurs de cd28/ctla-4, compositions pharmaceutiques renfermant ceux-ci et procede d'utilisation de ceux-ci
HU9801384D0 (en) Clostridium perfringeus vaccine
EP2172214A3 (fr) Antigènes de Chlamydia et fragments d'ADN correspondants, et leurs utilisations
DE69922212D1 (de) Impfstoff enthaltend zytokin-induzierte heat shock proteine (hsp)
NO20005482L (no) Rekombinant virus og anvendelser derav samt vaksine som omfatter nevnte virus.
IL149415A0 (en) Adjuvanted genetic vaccines
WO2001032204A3 (fr) Composition vaccinale a base d'acides nucleiques comportant un promoteur de gene cd80/cd86 mammalien suscitant une expression antigenique
SI1227840T1 (sl) Genetske vakcine z adjuvansom
NZ334649A (en) Iron regulated promoter derived from an aerobactin gene promoter